(Q37738717)

22 August 2017

1 reference

title

HIV, antiretroviral therapies, and the brain (English)

1 reference

22 August 2017

0 references

anti-retroviral agent

0 references

author name string

Kevin J Liner

series ordinal

1

1 reference

22 August 2017

Michelle J Ro

series ordinal

2

1 reference

22 August 2017

Kevin R Robertson

series ordinal

3

1 reference

22 August 2017

language of work or name

1 reference

1 May 2010

1 reference

22 August 2017

published in

Current HIV/AIDS reports

1 reference

22 August 2017

volume

7

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

85-91

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-010-0042-8

22 August 2017

exact match

0 references

cites work

Stepped-dose versus full-dose efavirenz for HIV infection and neuropsychiatric adverse events: a randomized trial.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11904-010-0042-8

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

21 January 2018

1 reference

12 December 2020

Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA).

1 reference

12 December 2020

Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors

1 reference

12 December 2020

Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.

1 reference

12 December 2020

Raltegravir cerebrospinal fluid concentrations in HIV-1 infection

1 reference

12 December 2020

Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.

1 reference

12 December 2020

Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line

1 reference

12 December 2020

Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia

1 reference

12 December 2020

HIV-associated episodic memory impairment: evidence of a possible differential deficit in source memory for complex visual stimuli

1 reference

12 December 2020

HIV-associated prospective memory impairment increases risk of dependence in everyday functioning

1 reference

12 December 2020

Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients.

1 reference

12 December 2020

Experimental approaches to the study of HIV-1 latency

1 reference

12 December 2020

The societal burden of HIV/AIDS in Northern Italy: an analysis of costs and quality of life.

1 reference

12 December 2020

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

1 reference

12 December 2020

Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors

1 reference

12 December 2020

The prevalence and incidence of neurocognitive impairment in the HAART era.

1 reference

12 December 2020

The challenge of finding a cure for HIV infection

1 reference

12 December 2020

Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals

1 reference

12 December 2020

Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review.

1 reference

12 December 2020

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

1 reference

12 December 2020

Neuropsychological assessment of HIV-infected populations in international settings

1 reference

12 December 2020

Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study

1 reference

12 December 2020

Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents

1 reference

12 December 2020

Cellular reservoirs of HIV-1 and their role in viral persistence

1 reference

12 December 2020

Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS.

1 reference

12 December 2020

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

1 reference

12 December 2020

Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles.

1 reference

12 December 2020

Functional consequences of HIV-associated neuropsychological impairment

1 reference

12 December 2020

HIV infection and psychiatric illness

1 reference

12 December 2020

NanoART, neuroAIDS and CNS drug delivery

1 reference

12 December 2020

Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course

1 reference

12 December 2020

Acute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients: clinical description and follow-up

1 reference

12 December 2020

HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda

1 reference

12 December 2020

Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India

1 reference

12 December 2020

Preclinical assessment of the distribution of maraviroc to potential human immunodeficiency virus (HIV) sanctuary sites in the central nervous system (CNS) and gut-associated lymphoid tissue (GALT)

1 reference

12 December 2020

Early antiretroviral treatment prevents the development of central nervous system abnormalities in simian immunodeficiency virus-infected rhesus monkeys

1 reference

12 December 2020

HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort Study

1 reference

12 December 2020

Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders

1 reference

12 December 2020

HIV and antiretroviral therapy in the brain: neuronal injury and repair

1 reference

12 December 2020

Effect of early versus deferred antiretroviral therapy for HIV on survival

1 reference

12 December 2020

Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda

1 reference

12 December 2020

Pharmacokinetics and drug-drug interactions of antiretrovirals: an update

1 reference

12 December 2020

Task shifting in HIV/AIDS: opportunities, challenges and proposed actions for sub-Saharan Africa

1 reference

12 December 2020

Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China

1 reference

12 December 2020

Low-level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T-cells

1 reference

12 December 2020

Updated research nosology for HIV-associated neurocognitive disorders

1 reference

12 December 2020

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

1 reference

12 December 2020

Inhibition of HIV fusion with multivalent gold nanoparticles

1 reference

12 December 2020

10.1007/S11904-010-0042-8

Identifiers

DOI

1 reference

22 August 2017

1 reference